Skip to main content
. 2018 May 3;32(3):669–675. doi: 10.21873/invivo.112292

Table III. Univariate and multivariate analysis with respect to progression-free survival in 34 patients with stage IV breast cancer.

graphic file with name in_vivo-32-673-i0001.jpg

CI, Confidence interval; ER, estrogen receptor; PgR, progesterone receptor; ORR, overall response rate; NLR, neutrophil-to-lymphocyte ratio.